Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals, Inc.
| MYLAN PHARMACEUTICALS, INC. and PFIZER, INC. |
| SANOFI-AVENTIS DEUTSCHLAND GMBH |
| 20-2034 |
| July 24, 2020 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 30, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 Note to File: The following cases are consolidated: 20-2033 Lead with 20-2034 and 20-2066 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [711392] [20-2033, 20-2034, 20-2066] [EKD] [Entered: 07/30/2020 04:14 PM] |
Filing 2
ORDER consolidating appeals 20-2033, 20-2034, and 20-2066. The Certified Lists are due no later than September 8, 2020. Service as of this date by the Clerk of Court. [711390] [20-2033, 20-2034, 20-2066] [EKD] [Entered: 07/30/2020 04:11 PM]
|
| Filing 1 Appeal docketed. Received: 07/15/2020. [709914] Entry of Appearance is due on 08/07/2020. Certificate of Interest is due on 08/07/2020. Docketing Statement is due on 08/07/2020. Certified List is due on 09/02/2020. [EKD] [Entered: 07/24/2020 11:23 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
